{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:12:48Z","timestamp":1761559968622,"version":"3.33.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1007\/s11894-002-0035-x","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T23:32:13Z","timestamp":1179617533000},"page":"31-36","source":"Crossref","is-referenced-by-count":25,"title":["Evolving pathophysiologic concepts in nonalcoholic steatohepatitis"],"prefix":"10.1007","volume":"4","author":[{"given":"Brent A.","family":"Neuschwander-Tetri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"35_CR1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, et al.: Nonalcoholic steatohepatitis. Mayo Clin Proc 1980, 55:434\u2013438.","journal-title":"Mayo Clin Proc"},{"key":"35_CR2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, et al.: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413\u20131419.","journal-title":"Gastroenterology"},{"key":"35_CR3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0168-8278(00)80301-3","volume":"33","author":"C Garc\u00eda-Monz\u00f3n","year":"2000","unstructured":"Garc\u00eda-Monz\u00f3n C, Mart\u00edn-P\u00e9rez E, Iacono OO, et al.: Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated to obesity. J Hepatol 2000, 33:716\u2013724.","journal-title":"J Hepatol"},{"key":"35_CR4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1572-0241.1999.01006.x","volume":"94","author":"D Sorbi","year":"1999","unstructured":"Sorbi D, Boynton J, Lindor KD: The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999, 94:1018\u20131022.","journal-title":"Am J Gastroenterol"},{"key":"35_CR5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF02208601","volume":"41","author":"HC Pinto","year":"1996","unstructured":"Pinto HC, Baptista A, Camilo ME, et al.: Nonalcoholic steatohepatitis: clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 1996, 41:172\u2013179.","journal-title":"Dig Dis Sci"},{"key":"35_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","volume":"21","author":"EM Brunt","year":"2001","unstructured":"Brunt EM: Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001, 21:3\u201316. An important viewpoint on the pathologic findings of NASH.","journal-title":"Semin Liver Dis"},{"key":"35_CR7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","volume":"107","author":"BR Bacon","year":"1994","unstructured":"Bacon BR, Farahvash MJ, Janney CG, et al.: Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994, 107:1103\u20131109.","journal-title":"Gastroenterology"},{"key":"35_CR8","first-page":"97","volume":"8","author":"T Andersen","year":"1984","unstructured":"Andersen T, Gluud C: Liver morphology in morbid obesity: a literature study. Int J Obes Relat Metab Disord 1984, 8:97\u2013106.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"35_CR9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0022-3476(95)70156-7","volume":"127","author":"AD Baldridge","year":"1995","unstructured":"Baldridge AD, Perez-Atayde AR, Graeme-Cook F, et al.: Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995, 127:700\u2013704.","journal-title":"J Pediatr"},{"key":"35_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-3476(94)70202-0","volume":"125","author":"P Vajro","year":"1994","unstructured":"Vajro P, Fontanella A, Perna C, et al.: Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994, 125:239\u2013241.","journal-title":"J Pediatr"},{"key":"35_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2001-12926","volume":"21","author":"Y Falck-Ytter","year":"2001","unstructured":"Falck-Ytter Y, Younossi ZM, Marchesini G, et al.: Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001, 21:17\u201326. The prevalence and natural history data are nicely summarized in this article.","journal-title":"Semin Liver Dis"},{"key":"35_CR12","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","volume":"30","author":"P Angulo","year":"1999","unstructured":"Angulo P, Keach JC, Batts KP, et al.: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999, 30:1356\u20131362.","journal-title":"Hepatology"},{"key":"35_CR13","first-page":"1","volume":"15","author":"B Lombardi","year":"1966","unstructured":"Lombardi B: Considerations on the pathogenesis of fatty liver. Lab Invest 1966, 15:1\u201320.","journal-title":"Lab Invest"},{"key":"35_CR14","first-page":"327","volume-title":"Hepatotoxicology","author":"MU Dianzani","year":"1991","unstructured":"Dianzani MU: Biochemical aspects of fatty liver. In Hepatotoxicology. Edited by Meeks RG, Harrison SD, Bull RJ. Boca Raton, FL: CRC Press; 1991:327\u2013398."},{"key":"35_CR15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1051\/rnd:19960404","volume":"36","author":"D Gruffat","year":"1996","unstructured":"Gruffat D, Durand D, Graulet B, et al.: Regulation of VLDL synthesis and secretion in the liver. Reprod Nutr Dev 1996, 36:375\u2013389.","journal-title":"Reprod Nutr Dev"},{"key":"35_CR16","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1073\/pnas.94.6.2557","volume":"94","author":"SQ Yang","year":"1997","unstructured":"Yang SQ, Lin HZ, Lane MD, et al.: Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997, 94:2557\u20132562.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"35_CR17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1053\/hupa.2000.8440","volume":"31","author":"K Washington","year":"2000","unstructured":"Washington K, Wright K, Shyr Y, et al.: Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver. Hum Pathol 2000, 31:822\u2013828.","journal-title":"Hum Pathol"},{"key":"35_CR18","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0016-5085(97)70158-6","volume":"112","author":"SL Friedman","year":"1997","unstructured":"Friedman SL: Closing in on the signals of hepatic fibrosis. Gastroenterology 1997, 112:1406\u20131414.","journal-title":"Gastroenterology"},{"key":"35_CR19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0168-8278(96)80238-8","volume":"25","author":"HL Reeves","year":"1996","unstructured":"Reeves HL, Burt AD, Wood S, et al.: Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J Hepatol 1996, 25:677\u2013683.","journal-title":"J Hepatol"},{"key":"35_CR20","first-page":"69","volume":"2","author":"IR Wanless","year":"1989","unstructured":"Wanless IR, Bargman J, Oreopoulos D, et al.: Subcapsular steatonecrosis of the liver in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity. Mod Pathol 1989, 2:69\u201374.","journal-title":"Mod Pathol"},{"key":"35_CR21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0168-8278(99)80301-8","volume":"31","author":"E Tankurt","year":"1999","unstructured":"Tankurt E, Biberoglu S, Ellidokuz E, et al.: Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis [letter]. J Hepatol 1999, 31:963\u2013968.","journal-title":"J Hepatol"},{"key":"35_CR22","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/j.1572-0241.2001.04667.x","volume":"96","author":"IR Willner","year":"2001","unstructured":"Willner IR, Waters B, Patil SR: Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency and severity of disease.Am J Gastroenterol 2001, 96:2957\u20132961.","journal-title":"Am J Gastroenterol"},{"key":"35_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3140001","volume":"314","author":"VA Zammit","year":"1996","unstructured":"Zammit VA: Role of insulin in hepatic fatty acid partitioning: emerging concepts. Biochem J 1996, 314:1\u201314.","journal-title":"Biochem J"},{"key":"35_CR24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","volume":"389","author":"KT Uysal","year":"1997","unstructured":"Uysal KT, Wiesbrock SM, Marino MW, et al.: Protection from obesity-induced insulin resistance in mice lacking TNF-_ function. Nature 1997, 389:610\u2013614.","journal-title":"Nature"},{"key":"35_CR25","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","volume":"283","author":"M Elchebly","year":"1999","unstructured":"Elchebly M, Payette P, Michaliszyn E, et al.: Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999, 283:1544\u20131548.","journal-title":"Science"},{"key":"35_CR26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor alpha: direct role in obesitylinked insulin resistance. Science 1993, 259:87\u201391.","journal-title":"Science"},{"key":"35_CR27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2337\/diabetes.48.1.94","volume":"48","author":"N Barzilai","year":"1999","unstructured":"Barzilai N, She L, Liu B-Q, et al.: Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999, 48:94\u201398.","journal-title":"Diabetes"},{"issue":"suppl 3","key":"35_CR28","first-page":"C10","volume":"22","author":"JD Brunzell","year":"1999","unstructured":"Brunzell JD, Hokanson JE: Dyslipidemia of central obesity and insulin resistance. Diabetes Care 1999, 22(suppl 3):C10-C13.","journal-title":"Diabetes Care"},{"key":"35_CR29","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/diabetes.47.9.1384","volume":"47","author":"CT Montague","year":"1998","unstructured":"Montague CT, Prins JB, Sanders L, et al.: Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998, 47:1384\u20131391.","journal-title":"Diabetes"},{"key":"35_CR30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","volume":"6","author":"MD Michael","year":"2000","unstructured":"Michael MD, Kulkarni RN, Postic C, et al.: Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000, 6:87\u201397.","journal-title":"Mol Cell"},{"key":"35_CR31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"CM Steppan","year":"2001","unstructured":"Steppan CM, Bailey ST, Bhat S, et al.: The hormone resistin links obesity to diabetes. Nature 2001, 409:307\u2013312.","journal-title":"Nature"},{"key":"35_CR32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2001-12931","volume":"21","author":"P Angulo","year":"2001","unstructured":"Angulo P, Lindor KD: Treatment of nonalcoholic fatty liver: present and emerging therapies. Semin Liver Dis 2001, 21:81\u201388. This is an extensive review of various treatments that have been tried.","journal-title":"Semin Liver Dis"},{"key":"35_CR33","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.510230624","volume":"23","author":"J Laurin","year":"1996","unstructured":"Laurin J, Lindor KD, Crippin JS, et al.: Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996, 23:1464\u20131467.","journal-title":"Hepatology"},{"key":"35_CR34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0092-8674(01)00239-2","volume":"104","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR: New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001, 104:517\u2013529.","journal-title":"Cell"},{"key":"35_CR35","first-page":"L0083","volume":"116","author":"WJ Coyle","year":"1999","unstructured":"Coyle WJ, Delaney N, Yoshihashi A, et al.: Metformin treatment in patients with nonalcoholic steatohepatitis normalizes LFTs and improves histology [abstract]. Gastroenterology 1999, 116:L0083.","journal-title":"Gastroenterology"},{"key":"35_CR36","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1210\/endo.139.12.6364","volume":"139","author":"JR Zierath","year":"1998","unstructured":"Zierath JR, Ryder JW, Doebber T, et al.: Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPAR_ agonist) action. Endocrinology 1998, 139:5034\u20135041.","journal-title":"Endocrinology"},{"key":"35_CR37","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","volume":"270","author":"JM Lehmann","year":"1995","unstructured":"Lehmann JM, Moore LB, Smith-Oliver TA, et al.: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor-_ (PPARgamma). J Biol Chem 1995, 270:12953\u201312956.","journal-title":"J Biol Chem"},{"key":"35_CR38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0889-8529(05)70267-X","volume":"26","author":"RR Henry","year":"1997","unstructured":"Henry RR: Thiazolidinediones. Endocrinol Metab Clin North Am 1997, 26:553\u2013573.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"35_CR39","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1172\/JCI118860","volume":"98","author":"P Vos De","year":"1996","unstructured":"De Vos P, Lefebvre A-M, Miller SG, et al.: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor _. J Clin Invest 1996, 98:1004\u20131009.","journal-title":"J Clin Invest"},{"key":"35_CR40","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1210\/endo.135.5.7956951","volume":"135","author":"J Ohsumi","year":"1994","unstructured":"Ohsumi J, Sakakibara S, Yamaguchi J, et al.: Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology 1994, 135:2279\u20132282.","journal-title":"Endocrinology"},{"key":"35_CR41","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/endo.136.4.7895657","volume":"136","author":"D Szalkowski","year":"1995","unstructured":"Szalkowski D, White-Carrington S, Berger J, et al.: Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 1995, 136:1474\u20131481.","journal-title":"Endocrinology"},{"key":"35_CR42","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.ATV.17.9.1756","volume":"17","author":"AM Lefebvre","year":"1997","unstructured":"Lefebvre AM, Peinado-Onsurbe J, Leitersdorf I, et al.: Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates. Arterioscler Thromb Vasc Biol 1997, 17:1756\u20131764.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"35_CR43","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.274.5291.1377","volume":"274","author":"GS Hotamisligil","year":"1996","unstructured":"Hotamisligil GS, Johnson RS, Distel RJ, et al.: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996, 274:1377\u20131379.","journal-title":"Science"},{"key":"35_CR44","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diab.44.9.1087","volume":"44","author":"PW Young","year":"1995","unstructured":"Young PW, Cawthorne MA, Coyle PJ, et al.: Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes: association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes 1995, 44:1087\u20131092.","journal-title":"Diabetes"},{"key":"35_CR45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI1244","volume":"101","author":"Z Wu","year":"1998","unstructured":"Wu Z, Xie Y, Morrison RF, et al.: PPAR_ induces the insulin-dependent glucose transporter GLUT4 in the absence of C\/EBP during the conversion of 3T3 fibroblasts into adipocytes. J Clin Invest 1998, 101:22\u201332.","journal-title":"J Clin Invest"},{"key":"35_CR46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1572-0241.2001.03553.x","volume":"96","author":"SH Caldwell","year":"2001","unstructured":"Caldwell SH, Hespenheide EE, Redick JA, et al.: A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterol 2001, 96:519\u2013525.","journal-title":"Am J Gastroenterol"},{"key":"35_CR47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2001-12930","volume":"21","author":"ES Siegelman","year":"2001","unstructured":"Siegelman ES, Rosen MA: Imaging of hepatic steatosis. Semin Liver Dis 2001, 21:71\u201380.","journal-title":"Semin Liver Dis"},{"key":"35_CR48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11894-000-0048-2","volume":"2","author":"EM Brunt","year":"2000","unstructured":"Brunt EM: Liver biopsy interpretation for the gastroenterologist. Curr Gastroenterol Rep 2000, 2:27\u201332.","journal-title":"Curr Gastroenterol Rep"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-002-0035-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-002-0035-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-002-0035-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T13:47:36Z","timestamp":1737035256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-002-0035-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1007\/s11894-002-0035-x","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"type":"print","value":"1522-8037"},{"type":"electronic","value":"1534-312X"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}